Introduction – Railroads as an Investment Option
Railroads – many of us cross over tracks everyday on our commute to work each day and some of us actually taking a train on a daily basis perhaps. Railroads have been around for a long time, moving all sorts of cargo from coast to coast. Railroad stocks took it on the chin not too long ago due to coal weakening and oil production being cut in conjunction with increased utilization of pipelines to transport gas and oil, but public railroad stocks can be an exceptional investment option in a growing economy as they move many materials and goods. They may not be an exciting investment but they sure can be effective – take a look at the chart below. Over the past five years, Union Pacific Corporation (NYSE:UNP), CSX Corporation (NYSE:CSX), and Canadian National Railway Company (NYSE:CNI) have all outperformed the S&P by as much as 58%.
Top Canadian Stocks To Buy For 2018: ConocoPhillips(COP)
- [By Shanthi Rexaline]
Phillips 66 is a multi-national company headquartered in Westchase, Houston. It was spun off from ConocoPhillips (NYSE: COP) in 1917.
Stock Return (Since 2012): 144.1 percent.
- [By WWW.THESTREET.COM]
The contract awards are for the jack-ups West Elara and West Linus with ConocoPhillips Skandinavia AS (COP) for work in the Greater Ekofisk area. The total additional backlog for the new contract awards is estimated to be about $1.4 billion, excluding performance bonuses.
- [By WWW.THESTREET.COM]
ConocoPhillips (COP) was upgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: COP.
Urban Outfitters (URBN) was downgraded to market perform at William Blair. Continued comp-store sales pressure is pushing out the timeline for a potential recovery, Blair said.
- [By Dustin Parrett]
Big Oil stocks are the seven “oil supermajors” that do everything from oil drilling to refining to retail sales. This is a list of the Big Oil companies:
Big Oil CompanyShare PriceYTDMarket CapExxon Mobil Corp. (NYSE: XOM)$83.44-7.58%$353.13BChevron Co. (NYSE: CVX)$113.56-3.5%$217.62BConocoPhillips Co. (NYSE: COP)$48.21-3.78%$61.42BRoyal Dutch Shell Plc. (NYSE ADR: RDS.A)$52.35-3.82%$221.08BBP Plc. (NYSE ADR: BP)$34.12-8.71%$112.69BTotal SA (NYSE: TOT)$50.26-1.35%$124.6BEni SpA (NYSE: E)$31.51-2.3%$58.69B
Despite being huge global oil companies, shares of Big Oil stocks are all in the red this year. Those losses have all happened even as the Dow is smashing record highs and trading up 6.4% year to date.
- [By WWW.KIPLINGER.COM]
Spun off from energy producer ConocoPhillips (COP) a few years back, PSX has quickly become one of the downstream industrys biggest players. Refiners earn profits based on the difference between feed stock costs (Think oil and natural gas prices) and the price for refined products such as gasoline, jet fuel and heating oil. Those inputs remain low, and Phillips 66 is minting cash as a result.
Top Canadian Stocks To Buy For 2018: Wells Fargo & Company(WFC)
- [By WWW.KIPLINGER.COM]
Cliches aside, Wells Fargo & Co. (WFC) might not be the most popular name after its phony accounts scandal, but so what? Its still a quality business with a quality stock that yields 3.4%.
- [By JPMorgan]
We recommend Wells Fargo into 2016 for several reasons: 1) a safe haven stock in a choppy, uncertain time period; 2) some benefit from acquisitions from GE Capital; 3) continued growth in several other areas – investment banking, credit cards, and payments; and 4) continued sizable capital return.
- [By Chris Dier-Scalise]
Among the brands being sold were Alcoa Corporation (NYSE: AA) and Ford Motor Company(NYSE: F), which both paid out dividends in December. The financial and oil sectors also experienced a sell-off to finish 2016. Wells Fargo & Co (NYSE: WFC) and Citigroup Inc (NYSE: C) were net sold as each reached new year-to-date highs and investors unloaded ConocoPhillips (NYSE: COP) and Chevron Corporation (NYSE: CVX) as their prices normalized with the rise in the price of oil.
- [By Ben Levisohn]
Big banks like JPMorgan Chase (JPM), Wells Fargo (WFC), and Bank of America (BAC) have surged more than 20% during the past three months–causing many investors to doubt the possibility for further gains. I’m note one of them–after my disastrous financials call last year, I’m bullish on them in 2017–and neither is Morgan Stanley’s Betsy Graseck, who remains Overweight the big banks, despite their big gains. She explains why:
- [By Ben Levisohn]
Bank stocks have had quite a run since Donald Trump’s 2016 presidential election victory–such a run, in fact that Baird’s David George and team worry that most of the benefits of “potential improvement in macro growth, regulatory relief, and corporate tax reform” seem priced into their stocks. They recommend investors “selectively reduce bank exposure” but still like Wells Fargo (WFC), which they call a “top buy idea.” They explain why:
Top Canadian Stocks To Buy For 2018: Nu Skin Enterprises Inc.(NUS)
- [By Scott Rubin]
Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.
- [By Roberto Pedone]
Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.
Monday’s Volume: 2 million
Three-Month Average Volume: 900,802
Volume % Change: 85%
From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.
Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.
- [By Craig Jones]
Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.
- [By Ben Levisohn]
Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:
“Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…
Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.
Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.
Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.
Top Canadian Stocks To Buy For 2018: Valeant Pharmaceuticals International Inc(VRX)
- [By Kumar Abhishek]
Shares of specialty pharma company Valeant Pharmaceuticals Intl Inc(NYSE:VRX)have tanked more than 20% in last two trading sessions, breaching the support from the 50 day SMA, after the Laval,Quebec-based company reported its Q4 and FY 2016 earnings on Tuesday, before the market opened. While the earnings itself were better than expected, the guidance for FY 2017 didn’t go down well with investors and wall street, earning the company multiple price target cuts. Valeant reported an adjusted profit of $1.26 a share against analysts’ estimateof $1.21. This was Valeant’s first beat in a long time. Even on the revenue front, the company reported better than expected results. Initially, the stock gained on the report of an earnings beat. However, once the guidance figures came in, the stock tanked. In our earnings preview of Valeant, we had said that the adjusted EBITDA guidance for 2017 will be the key driver of VRX stock after the earnings.
- [By Benzinga News Desk]
Just days after Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares took a steep tumble below the $11 level, the stock is almost back to an important level at $12: Link
- [By Ashley Moore]
The current rally of Valeant Pharmaceuticals International Inc. (NYSE: VRX) is being driven by two things. While investors are viewing these two catalysts as bullish, they are really just temporary solutions.
- [By Casey Wilson]
As disgraceful as Mylan’s pricing strategy may be, this next pharmaceutical firm is hated even more – and makes our list for the second year in a row…
Most-Hated Companies 2016 No. 1: Valeant Pharmaceuticals International Inc. (NYSE: VRX)
The troubled pharmaceutical company is deeply loathed by both consumers and investors alike.